Tag: Immunotherapy
New Hope for Endometrial Cancer Patients with FDA-Approved Immunotherapy
The U.S. Food and Drug Administration (FDA) recently approved a new drug called Jemperli (dostarlimab-gxly) for certain adult patients with endometrial cancer. This drug, developed by British pharmaceutical company GSK, is designed for individuals...
New FDA-Approved Drug for Autoimmune Liver Disease: A Breakthrough Treatment
A breakthrough treatment for autoimmune liver disease has been approved by the U.S. Food and Drug Administration (FDA). The medication, Iqirvo (elafibranor), developed by French drugmaker Ipsen, is a new 80 mg tablet that...
More Progress With Less Intensive Treatment, Crucial New Research For People Battling Cancers Like...
New Breakthroughs in Cancer Treatment: Less Intensive Therapy Shows Promise for Ovarian, Esophageal, and Hodgkin Lymphoma PatientsNew research presented at the 2024 American Society of Clinical Oncology (ASCO) annual meeting has shed light on...
Pfizer’s Lung Cancer Drug Is Extending Survival Rates and Stopping Cancer Spread
Pfizer's Lung Cancer Drug Shows Significant Progress in TreatmentKey Takeaways• A recent study revealed that a drug called Lorbrena has shown impressive results in extending survival rates and halting the spread of lung cancer.
•...
Scientists find new method to enhance efficacy of bispecific antibodies for solid tumors
Breakthrough Study Reveals Innovative Approach to Boost Effectiveness of Bispecific Antibodies in Solid Tumor TreatmentA recent study has unveiled a groundbreaking method to enhance the efficacy of bispecific antibody therapies for solid tumors. The...
Precision matching for kidney transplants: BC project targets reduced rejections and elimination of need...
Breaking News: Revolutionary Project Aims to Revolutionize Kidney TransplantsIn a groundbreaking initiative, a project in British Columbia is targeting precision matching for kidney transplants in order to reduce rejections and eliminate the need for...
Ovarian Cancer Drugs Market to Reach USD 9,857 Million by 2032 | Market.us
Ovarian Cancer Drugs Market Projected to Reach USD 9,857 Million by 2032In recent market analysis, the Global Ovarian Cancer Drugs Market is expected to reach a value of USD 9,857 million by the year...
Giving babies smooth peanut butter could provide lifelong allergy defence
Preventing Peanut Allergy in BabiesIn a groundbreaking study conducted by researchers at King's College London, it has been revealed that giving smooth peanut butter to babies and young children could provide lifelong protection against...
New strain of vaccinia virus can induce immunogenic cell death in tumors
New Immunogenic Vaccinia Virus Strain Shows Promise in Cancer TreatmentA recent study conducted by the University of Barcelona and other research institutions has unveiled a groundbreaking new strain of the vaccinia virus that has...